
Femicef S 250mg/125mg Injection
Marketer
Eminent Healthcare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Femicef S 250mg/125mg Injection
Cefixime and Sulbactam injection (250mg/125mg), sold as Femicef S, combats bacterial infections by inhibiting microbial growth. Administration must be under a doctor's supervision; complete the prescribed course, even with symptom improvement, to prevent treatment failure. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions (allergic or otherwise) necessitate immediate medical attention. Inform your physician about all other medications, including those for pre-existing conditions, prior to use. Pregnant or lactating individuals should consult their doctor. Alcohol should be avoided due to potential drowsiness. While generally driving ability isn't affected, avoid driving if experiencing dizziness or somnolence. Adequate rest, nutrition, and hydration support recovery. Your physician may order tests to monitor the medicine's efficacy.
Primary Ingredients of Femicef S 250mg/125mg Injection
The provided text is "undefined," which cannot be rephrased while maintaining meaning and intent. There is no original text to rewrite.
Uses of Femicef S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Femicef S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Femicef S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Femicef S 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Femicef S 250mg/125mg Injection works:
Femicef S Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, combines an antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counters bacterial resistance, optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Femicef S 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Femicef S 250mg/125mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human clinical trials are scarce.
Breast feedingCAUTION
Administering Femicef S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Femicef S 250mg/125mg Injection may induce drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Femicef S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Femicef S (250mg/125mg) requires careful administration in individuals with advanced hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Dosage alterations for Femicef S (250mg/125mg) injection are not advised for those experiencing mild or moderate liver dysfunction.
What if you forget to take Femicef S 250mg/125mg Injection :
Omitting a scheduled dose of Femicef S 250mg/125mg Injection warrants immediate physician consultation.
Facts to Know About Femicef S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
